UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 530

Sortiert nach

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

European heart journal, 2012-05, Vol.33 (9), p.1049-1057

2012

Link zum Volltext

Verfügbarkeit prüfen

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

Clinical pharmacology and therapeutics, 2012-03, Vol.91 (3), p.426-437

2012

Link zum Volltext

Verfügbarkeit prüfen

What are the main environmental factors driving the development of the neurotoxic dinoflagellate Vulcanodinium rugosum in a Mediterranean ecosystem (Ingril lagoon, France)?

Harmful algae, 2018-05, Vol.75, p.75-86

2018

Link zum Volltext

Verfügbarkeit prüfen

Rosiglitazone: a European regulatory perspective

Diabetologia, 2011-02, Vol.54 (2), p.213-218

2011

Link zum Volltext

Verfügbarkeit prüfen

Response of diatom and dinoflagellate lifeforms to reduced phosphorus loading: A case study in the Thau lagoon, France

Estuarine, coastal and shelf science, 2015-09, Vol.162, p.45-52

2015

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Annals of the Rheumatic Diseases, 2011-10, Vol.70 (10), p.1713-1718

2011

Link zum Volltext

Verfügbarkeit prüfen

need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

Osteoporosis international, 2010-05, Vol.21 (5), p.713-722

2010

Link zum Volltext

Verfügbarkeit prüfen

10. Extended evaluation of mixed-mode and lipophilic sorbents for passive sampling of marine toxins

Toxicon (Oxford), 2014-12, Vol.91, p.168-169

2014

Link zum Volltext

Verfügbarkeit prüfen

Variation in Health Technology Assessment and Reimbursement Processes in Europe

Value in health, 2017, Vol.20 (1), p.67-76

2017

Link zum Volltext

Verfügbarkeit prüfen

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis

Osteoarthritis and cartilage, 2005, Vol.13 (1), p.13-19

2005

Link zum Volltext

Verfügbarkeit prüfen

Cellular models and cytotoxicity of pinnatoxin-G and extracts of the dinoflagellate Vulcanodinium rugosum recently isolated from the French mediterranean lagoon of Ingril

Toxicon (Oxford), 2013-12, Vol.75, p.215-216

2013

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Syndrome, New Onset Diabetes, and New End points in Cardiovascular Trials

Journal of cardiovascular pharmacology, 2006-03, Vol.47 (3), p.469-475

2006

Link zum Volltext

Verfügbarkeit prüfen

Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis

The European respiratory journal, 2017-12, Vol.50 (6), p.1702023-1702023

2017

Link zum Volltext

Verfügbarkeit prüfen

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

Nature reviews. Drug discovery, 2010-04, Vol.9 (4), p.277-291

2010

Link zum Volltext

Verfügbarkeit prüfen

European regulatory perspectives for innovative therapies

Osteoporosis international, 2008-06, Vol.19 (6), p.725-731

2008

Link zum Volltext

Verfügbarkeit prüfen

Recurrent Selection for Partial Resistance to Crown Rust in Oat

Crop science, 2002-09, Vol.42 (5), p.1475-1482

2002

Link zum Volltext

Verfügbarkeit prüfen

Oligotrophication and emergence of picocyanobacteria and a toxic dinoflagellate in Thau lagoon, southern France

Journal of sea research, 2009-01, Vol.61 (1), p.68-75

2009

Link zum Volltext

Verfügbarkeit prüfen

A comparative analysis of Alexandrium catenella/tamarense blooms in Annaba Bay (Algeria) and Thau lagoon (France); phosphorus limitation as a trigger

Comptes rendus. Biologies, 2014-02, Vol.337 (2), p.117-122

2014

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers for Alzheimer's disease therapeutic trials

Progress in neurobiology, 2011-12, Vol.95 (4), p.579

2011

Link zum Volltext

Verfügbarkeit prüfen

Uncertain future of trials in osteoporosis

Osteoporosis international, 2002-01, Vol.13 (6), p.443-449

2002

Link zum Volltext

Verfügbarkeit prüfen

Background for studies on the treatment of male osteoporosis: state of the art

Annals of the rheumatic diseases, 2000-10, Vol.59 (10), p.765-772

2000

Link zum Volltext

Verfügbarkeit prüfen

Report on the first detection of pectenotoxin-2, spirolide-a and their derivatives in French shellfish

Marine drugs, 2007-11, Vol.5 (4), p.168-179

2007

Link zum Volltext

Verfügbarkeit prüfen

The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis

Osteoporosis international, 2002-01, Vol.13 (1), p.1-5

2002

Link zum Volltext

Verfügbarkeit prüfen

Study Design in Osteoporosis: A European Perspective

Journal of bone and mineral research, 2003-06, Vol.18 (6), p.1133-1138

2003

Link zum Volltext

Verfügbarkeit prüfen

A feedback mechanism to control apoptosis occurs in the digestive gland of the oyster crassostrea gigas exposed to the paralytic shellfish toxins producer Alexandrium catenella

Marine drugs, 2014-09, Vol.12 (9), p.5035-5054

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 530

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(425)
Mit Volltextzugriff
(455)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Life Sciences & Biomedicine
(167)
Humans
(162)
Female
(94)
Male
(75)
Biological And Medical Sciences
(73)
Adult
(56)
Medical Sciences
(53)
Physical Sciences
(44)
Middle Aged
(43)
Aged
(41)
Animals
(41)
Life Sciences
(35)
Physics
(29)
Technology
(27)
Fundamental And Applied Biological Sciences. Psychology
(24)
General & Internal Medicine
(23)
Astrophysics
(22)
Treatment Outcome
(21)
Astronomy & Astrophysics
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

What are the main environmental factors driving the development of the neurotoxic dinoflagellate Vulcanodinium rugosum in a Mediterranean ecosystem (Ingril lagoon, France)?

Rosiglitazone: a European regulatory perspective

Response of diatom and dinoflagellate lifeforms to reduced phosphorus loading: A case study in the Thau lagoon, France

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

10. Extended evaluation of mixed-mode and lipophilic sorbents for passive sampling of marine toxins

Variation in Health Technology Assessment and Reimbursement Processes in Europe

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis

Cellular models and cytotoxicity of pinnatoxin-G and extracts of the dinoflagellate Vulcanodinium rugosum recently isolated from the French mediterranean lagoon of Ingril

Metabolic Syndrome, New Onset Diabetes, and New End points in Cardiovascular Trials

Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

European regulatory perspectives for innovative therapies

Recurrent Selection for Partial Resistance to Crown Rust in Oat

Oligotrophication and emergence of picocyanobacteria and a toxic dinoflagellate in Thau lagoon, southern France

A comparative analysis of Alexandrium catenella/tamarense blooms in Annaba Bay (Algeria) and Thau lagoon (France); phosphorus limitation as a trigger

Biomarkers for Alzheimer's disease therapeutic trials

Uncertain future of trials in osteoporosis

Background for studies on the treatment of male osteoporosis: state of the art

Report on the first detection of pectenotoxin-2, spirolide-a and their derivatives in French shellfish

The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis

Study Design in Osteoporosis: A European Perspective

A feedback mechanism to control apoptosis occurs in the digestive gland of the oyster crassostrea gigas exposed to the paralytic shellfish toxins producer Alexandrium catenella

Suchergebnisse filtern